| Item | Cat. No. | Application | Isotype |
| Anti-FLT1 mAbs [Icrucumab Biosimilar] (MABL-4785) | MABL-4785 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF5/CD40 mAbs [Giloralimab Biosimilar] (MABL-4754) | MABL-4754 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1 (Canine) mAbs [Gilvetmab Biosimilar] (MABL-4755) | MABL-4755 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-TNFRSF4/CD134/OX40 mAbs [Gimistotug Biosimilar] (MABL-4756) | MABL-4756 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CSF2 mAbs [Gimsilumab Biosimilar] (MABL-4757) | MABL-4757 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-GREM1 mAbs [Ginisortamab Biosimilar] (MABL-4758) | MABL-4758 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CA9 mAbs [Girentuximab Biosimilar] (MABL-4759) | MABL-4759 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CLDN18;TNFRSF9/CD137/4-1BB mAbs [Givastomig Biosimilar] (MABL-4760) | MABL-4760 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Lambda |
| Anti-GPNMB mAbs [Glembatumumab Biosimilar] (MABL-4761) | MABL-4761 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-GP6 mAbs [Glenzocimab Biosimilar] (MABL-4762) | MABL-4762 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3E;MS4A1/CD20 mAbs [Glofitamab Biosimilar] (MABL-4763) | MABL-4763 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Lambda;Kappa |
| Anti-CD3E;ALB mAbs [Gocatamig1 Biosimilar] (MABL-4764) | MABL-4764 | ELISA, FACS, Functional assay, in vivo binding | na;na, Lambda;na |
| Anti-DLL3 mAbs [Gocatamig2 Biosimilar] (MABL-4765) | MABL-4765 | ELISA, FACS, Functional assay, in vivo binding | na, na |
| Anti-TNF/TNFA mAbs [Golimumab Biosimilar] (MABL-4766) | MABL-4766 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-OLR1/LOX1 mAbs [Golocdacimab Biosimilar] (MABL-4767) | MABL-4767 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-Respiratory Syncytial Virus Glycoprotein F;Respiratory Syncytial Virus Glycoprotein F mAbs [Gon | MABL-4768 | ELISA, FACS, Functional assay, in vivo binding | na;na, na;na |
| Anti-IGF1R/CD221 mAbs [Ganitumab Biosimilar] (MABL-4741) | MABL-4741 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-APP mAbs [Gantenerumab Biosimilar] (MABL-4742) | MABL-4742 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-F12 mAbs [Garadacimab Biosimilar] (MABL-4743) | MABL-4743 | ELISA, FACS, Functional assay, in vivo binding | G4, Lambda |
| Anti-CLDN18 mAbs [Garetatug Biosimilar] (MABL-4744) | MABL-4744 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
